EPKINLY

Indicated For

DLBCL, FL

About This Medication

# Genmab Patient Assistance Program Patient Guide: How to Get EPKINLY (epcoritamab-bysp) at Low or No Cost EPKINLY (epcoritamab-bysp) is a prescription medication used to treat certain types of relapsed or refractory lymphomas, and the **Genmab Patient Assistance Program (GPAP)**, part of MyNavCare Patient Support, provides free medication to eligible uninsured or underinsured patients facing financial hardship[1][5][8][9]. This guide explains eligibility, application steps, and support options in simple terms to help you access treatment without high costs. ## About EPKINLY and Why Assistance Matters **EPKINLY** is an injectable bispecific antibody approved for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), including DLBCL from indolent lymphoma and high-grade B-cell lymphoma after at least two prior therapies, and for relapsed or refractory follicular lymphoma after at least two lines of therapy[8]. Administered by a healthcare professional in a clinical setting, it targets cancer cells to help your immune system fight them. Treatment costs can exceed tens of thousands per cycle without insurance or aid, making programs like GPAP essential for many patients[2][4][10]. MyNavCare by Genmab offers comprehensive support, including GPAP for free medicine, co-pay help for commercially insured patients, benefits verification, prior authorization assistance, and patient education[1][3][7][9][10]. GPAP specifically targets those who cannot afford therapy due to lack of coverage or low income[1][5][9]. ## Who Qualifies for GPAP? GPAP is for **uninsured or underinsured patients** who meet financial eligibility based on income verification[1][5][9]. Exact income thresholds (e.g., Federal Poverty Level percentages) are not publicly detailed but require supporting documents to confirm household income and lack of resources[1][3]. Patients must have a valid prescription for EPKINLY from a licensed provider and consent to program rules, including no reimbursement from other sources if receiving free drug[1][2]. Those with commercial insurance may qualify for separate MyNavCare co-pay assistance instead[1][9]. Medicare or government insurance patients are typically directed to independent foundations[9]. ## Income Eligibility Breakdown Eligibility hinges on income authentication, but specific limits are evaluated case-by-case[1][3]. Here's a general overview based on common PAP structures (contact program for your situation): | Household Size | Estimated Max Income (300% FPL example)* | Notes | |---------------|-----------------------------------------|-------| | Individual | ~$45,180 annually | Requires proof like tax returns[1] | | Couple | ~$61,320 annually | Household income combined[3] | | Family of 3 | ~$77,460 annually | Includes dependents[1] | | Family of 4 | ~$93,600 annually | Adjusted yearly; verify current FPL[3] | *Hypothetical based on 2026 FPL; GPAP assesses individually with documents. No public FPL% specified[1][5]. Provide recent pay stubs, W-2s, or 1040 forms[1]. ## Insurance Requirements - **Uninsured patients**: Primary candidates for GPAP free medication[5][9]. - **Underinsured**: May qualify if out-of-pocket costs are unaffordable after insurance[1]. - **Commercial insurance**: Use MyNavCare Co-pay Program, not GPAP[1][9]. - **Medicare/Medicaid**: Often ineligible for GPAP; program refers to third-party foundations with separate criteria[9]. Full insurance details must be provided on the enrollment form for benefits verification[1][3]. ## Step-by-Step Application Process Applying involves your healthcare provider (HCP) and patient together via the MyNavCare Enrollment Form[1][3][5]. 1. **Discuss with your doctor**: Confirm EPKINLY prescription and ask them to initiate enrollment[8][10]. 2. **Complete Enrollment Form**: Patient fills personal info, consents to income verification (GPAP section), and authorizes MyNavCare services. HCP adds prescriber details, diagnosis (e.g., DLBCL ICD code), treatment plan, and insurance info[1][3][6]. 3. **Sign Patient Authorization Form**: Required for all; optional care partner designation. Sign electronically via DocuSign at MyNavCare.com or fax[6][9]. 4. **Submit documents**: Fax to 1-866-628-2276 or use MyNavCareHCPportal.com. Include income proof[1][5][6]. Self-enroll online at MyNavCare.com by clicking 'Enroll Now' for DocuSign[9]. 5. **Phone support**: Call 1-866-NAV-CAR1 (1-866-628-2271), Mon-Fri 8AM-8PM ET for help[1][10]. HCP and patient must both complete; incomplete forms delay processing[1][3]. ## Timeline and Delivery Processing time varies; expect review after submission, with income verification potentially adding days to weeks[1]. Once approved, medication ships to your HCP's office, specialty pharmacy, or site of care (e.g., buy & bill)[1]. Track via MyNavCare support. Reauthorization may be needed periodically based on ongoing eligibility[1]. ## Alternatives if Denied or Ineligible - **Appeal**: Request via MyNavCare for prior auth support[1]. - **Co-pay program**: For commercial insurance[9]. - **Independent foundations**: Program provides referrals (eligibility separate)[9]. - **Other PAPs**: Check AbbVie resources (co-manufacturer) or general lymphoma funds. - **Contact support**: 1-866-628-2271 for personalized options[10]. No biosimilar alternatives available[program data]. ## Important Disclaimer This guide is for informational purposes based on available program details as of 2026 and is not medical or financial advice. Eligibility, terms, and availability can change; always verify with Genmab at 1-866-628-2271 or MyNavCare.com. Consult your doctor for treatment decisions. Genmab/GPAP not liable for application outcomes[1][2]. (Word count: 1028)

Program information last verified: March 30, 2026